Indivior Pharmaceuticals, Inc. INDV Proceeds from disposal of certain strategic investments

Proceeds from disposal of certain strategic investments at other companies

Jackson FinancialJXN

$16M+300%

First American FinancialFAF

$1.4M-90.7%

AllstateALL

$4.06B+188%

Western Alliance BancorporationWAL

$0-100%

The Hanover Insurance GroupTHG

$38.3M+86.8%

MTD

Matador ResourcesMTDR

$5.61M+81.3%

Other financials

Income statement

See full

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

See full

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

See full

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

See full

Market cap$4.53B+213%

Profitability

See full

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

FCF margin-14.9%—

Returns & leverage

See full

Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's proceeds from disposal of certain strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's proceeds from disposal of certain strategic investments?: Indivior Pharmaceuticals, Inc. (INDV) reported proceeds from disposal of certain strategic investments of $250K in Q4 2025.